The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $22.03

Today's change+0.23 +1.06%
Updated May 6 4:00 PM EDT. Delayed by at least 15 minutes.
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $22.03

Today's change+0.23 +1.06%
Updated May 6 4:00 PM EDT. Delayed by at least 15 minutes.

Boston Scientific Corp up (U.S.)$0.23

Boston Scientific Corp closed up Friday by (U.S.)$0.23 or 1.06% to (U.S.)$22.03. Over the last five days, shares have gained 0.50% and are currently 1.72% off of the 52-week high. Shares have outperformed the S&P 500 by 28.45% during the last year.

Key company metrics

  • Open(U.S.) $21.72
  • Previous close(U.S.) $21.80
  • High(U.S.) $22.08
  • Low(U.S.) $21.64
  • Bid / Ask(U.S.) $22.00 / (U.S.) $22.05
  • YTD % change+19.47%
  • Volume9,714,580
  • Average volume (10-day)15,489,829
  • Average volume (1-month)10,543,800
  • Average volume (3-month)10,149,878
  • 52-week range(U.S.) $14.18 to (U.S.) $22.42
  • Beta1.00
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward20.04×
  • Forward PEG1.63×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.18
Updated May 6 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue1,9781,8881,8431,768
Total other revenue--------
Total revenue1,9781,8881,8431,768
Gross profit1,4161,3541,3111,256
Total cost of revenue562534532512
Total operating expense2,2492,1871,6241,744
Selling / general / administrative774720696660
Research & development244221220192
Depreciation / amortization134131116113
Interest expense (income), net operating--------
Unusual expense (income)51856442250
Other operating expenses, total17171817
Operating income-271-29921924
Interest income (expense), net non-operating-59-58-106-60
Gain (loss) on sale of assets--------
Other--------
Income before tax-338-367105-51
Income after tax-142-198102-1
Income tax, total-196-1693-50
Net income-142-198102-1
Total adjustments to net income--------
Net income before extra. items-142-198102-1
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-142-198102-1
Inc. avail. to common incl. extra. items-142-198102-1
Diluted net income-142-198102-1
Dilution adjustment--------
Diluted weighted average shares1,3461,3441,3621,334
Diluted EPS excluding extraordinary itemsvalue per share-0.11-0.150.070.00
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.140.130.100.12